8.74 USD
-0.02 (-0.23%)
8.74 USD
0 (0%)
JYNT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While JYNT seems to be doing ok healthwise, there are quite some concerns on its profitability. JYNT is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
JYNT had negative earnings in the past year.
JYNT had a positive operating cash flow in the past year.
In multiple years JYNT reported negative net income over the last 5 years.
In the past 5 years JYNT always reported a positive cash flow from operatings.
1.2 Ratios
JYNT has a Return On Assets (-1.40%) which is in line with its industry peers.
JYNT has a Return On Equity (-4.27%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROIC | N/A |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
JYNT has a better Gross Margin (78.26%) than 93.07% of its industry peers.
JYNT's Gross Margin has declined in the last couple of years.
JYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
2. Health
2.1 Basic Checks
JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
JYNT has more shares outstanding than it did 1 year ago.
JYNT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
JYNT has an Altman-Z score of 2.78. This is not the best score and indicates that JYNT is in the grey zone with still only limited risk for bankruptcy at the moment.
JYNT's Altman-Z score of 2.78 is in line compared to the rest of the industry. JYNT outperforms 59.41% of its industry peers.
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.78 |
ROIC/WACCN/A
WACC8.96%
2.3 Liquidity
JYNT has a Current Ratio of 1.83. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.83, JYNT is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
JYNT has a Quick Ratio of 1.83. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of JYNT (1.83) is better than 74.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 99.03% over the past year.
The Revenue for JYNT has decreased by -24.15% in the past year. This is quite bad
JYNT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.36% yearly.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
3.2 Future
The Earnings Per Share is expected to grow by 44.54% on average over the next years. This is a very strong growth
Based on estimates for the next years, JYNT will show a very negative growth in Revenue. The Revenue will decrease by -22.13% on average per year.
EPS Next Y84.93%
EPS Next 2Y105.18%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year-54.7%
Revenue Next 2Y-30.66%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 17.98, the valuation of JYNT can be described as rather expensive.
JYNT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. JYNT is cheaper than 69.31% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.40, JYNT is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 17.98 |
4.2 Price Multiples
JYNT's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 79.61 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JYNT's earnings are expected to grow with 44.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y105.18%
EPS Next 3Y44.54%
5. Dividend
5.1 Amount
No dividends for JYNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
8.74
-0.02 (-0.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners78.62%
Inst Owner Change-1.63%
Ins Owners22.81%
Ins Owner Change2.03%
Market Cap129.96M
Revenue(TTM)91.63M
Net Income(TTM)-970.20K
Analysts76.36
Price Target10.97 (25.51%)
Short Float %7.28%
Short Ratio7.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-14.21%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)-1.53%
Revenue beat(8)3
Avg Revenue beat(8)-6.24%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)5
Avg Revenue beat(16)-4.04%
PT rev (1m)0%
PT rev (3m)-27.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.29%
EPS NY rev (1m)-1200%
EPS NY rev (3m)-1200%
Revenue NQ rev (1m)-1.72%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)-1.47%
Revenue NY rev (3m)-1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 17.98 | ||
| P/S | 1.42 | ||
| P/FCF | 79.61 | ||
| P/OCF | 42.32 | ||
| P/B | 5.73 | ||
| P/tB | 5.73 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.49
Fwd EY5.56%
FCF(TTM)0.11
FCFY1.26%
OCF(TTM)0.21
OCFY2.36%
SpS6.16
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% | ||
| FCFM | 1.78% |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 78.79% | ||
| Cap/Sales | 1.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.78 |
F-Score6
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y84.93%
EPS Next 2Y105.18%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.7%
Revenue Next 2Y-30.66%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
EBIT growth 1Y-575.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year312.75%
EBIT Next 3Y60.95%
EBIT Next 5YN/A
FCF growth 1Y-85.24%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-81.35%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%
JOINT CORP/THE / JYNT FAQ
What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?
ChartMill assigns a fundamental rating of 4 / 10 to JYNT.
What is the valuation status for JYNT stock?
ChartMill assigns a valuation rating of 4 / 10 to JOINT CORP/THE (JYNT). This can be considered as Fairly Valued.
How profitable is JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a profitability rating of 3 / 10.
Can you provide the expected EPS growth for JYNT stock?
The Earnings per Share (EPS) of JOINT CORP/THE (JYNT) is expected to grow by 84.93% in the next year.